Molica, Serena
 Distribuzione geografica
Continente #
NA - Nord America 133
AS - Asia 107
EU - Europa 81
SA - Sud America 19
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 343
Nazione #
US - Stati Uniti d'America 129
SG - Singapore 56
IT - Italia 26
SE - Svezia 19
BR - Brasile 16
CN - Cina 15
IN - India 10
DE - Germania 9
FI - Finlandia 9
VN - Vietnam 8
FR - Francia 7
IE - Irlanda 5
JP - Giappone 5
GB - Regno Unito 3
HK - Hong Kong 3
ID - Indonesia 3
MX - Messico 3
AR - Argentina 2
BD - Bangladesh 2
JO - Giordania 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 343
Città #
Singapore 35
San Jose 19
New York 18
Ashburn 13
Chandler 11
Helsinki 8
Florence 6
Hyderabad 6
Dublin 5
Tokyo 5
Tukwila 5
Council Bluffs 4
Dallas 4
Atlanta 3
Beijing 3
Frankfurt am Main 3
Ho Chi Minh City 3
Hong Kong 3
Jakarta 3
Los Angeles 3
Rome 3
San Mateo 3
Amman 2
Boston 2
Colorado Springs 2
Düsseldorf 2
Hanoi 2
Hefei 2
Lauterbourg 2
Princeton 2
Pune 2
Quận Bình Thạnh 2
Agadir 1
Almirante Brown 1
Brasília 1
Bremen 1
Buenos Aires 1
Buffalo 1
Chicago 1
Cleveland 1
Curitiba 1
Denver 1
Detroit 1
Dhaka 1
Feira de Santana 1
Guarulhos 1
Itatiba 1
Jackson 1
Jaguariaíva 1
Johannesburg 1
Karachi 1
Kent 1
Lappeenranta 1
Manaus 1
Manchester 1
Marseille 1
Marília 1
Miguel Hidalgo 1
Milan 1
Montes Claros 1
Moscow 1
Mumbai 1
Muniz Freire 1
Naples 1
New Delhi 1
North Bergen 1
Norwalk 1
Nova Iguaçu 1
Orem 1
Orlando 1
Passo Fundo 1
Petersburg 1
Phoenix 1
Poplar 1
Recife 1
Rock Hill 1
Salvador 1
Santa Fe 1
Santa Rita 1
Seoul 1
Springfield 1
Stockholm 1
Subang Jaya 1
Taquarussu 1
Toronto 1
Valinhos 1
Venustiano Carranza 1
Vergiate 1
Vũng Tàu 1
Warner Robins 1
Wilmington 1
Yonkers 1
Totale 246
Nome #
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 134
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 110
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 102
Totale 346
Categoria #
all - tutte 1.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 3 4 1 0 0 4 1 0 6 1
2022/202333 6 7 2 4 0 5 1 2 1 0 5 0
2023/202448 1 8 2 6 1 17 2 2 0 1 0 8
2024/202566 1 3 5 0 6 4 0 3 9 13 12 10
2025/2026176 26 5 15 25 29 14 30 3 10 9 7 3
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 346